<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Translocations of the MLL gene at chromosome band 11q23 are the most common cytogenetic alterations in de novo <z:hpo ids='HP_0001909'>leukemia</z:hpo> in infants and in <z:hpo ids='HP_0001909'>leukemia</z:hpo> related to chemotherapy with DNA <z:chebi fb="0" ids="50750">topoisomerase II inhibitors</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Experiments on knock-in mice suggest that additional mutational events may by required for full <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we used single-strand conformation polymorphism analysis and an allele-specific restriction enzyme assay to investigate the frequency of KRAS and NRAS mutations in 32 pediatric <z:hpo ids='HP_0001909'>leukemias</z:hpo> with translocation of the MLL gene </plain></SENT>
<SENT sid="3" pm="."><plain>Of 25 de novo cases, 13 were <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), 10 were <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), and 2 were biphenotypic </plain></SENT>
<SENT sid="4" pm="."><plain>Three secondary <z:hpo ids='HP_0001909'>leukemias</z:hpo> were <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, 1 was biphenotypic, 1 was ALL, and 2 were diagnosed as <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of <z:mp ids='MP_0011356'>RAS</z:mp> mutations was 2 of 10 in de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Both mutations occurred in infant monoblastic variants </plain></SENT>
<SENT sid="7" pm="."><plain><z:mp ids='MP_0011356'>RAS</z:mp> mutations were otherwise absent in this series </plain></SENT>
<SENT sid="8" pm="."><plain>This is the first report of congenital <z:hpo ids='HP_0001909'>leukemias</z:hpo> where translocation of the MLL gene and <z:mp ids='MP_0011356'>RAS</z:mp> mutation coexist </plain></SENT>
<SENT sid="9" pm="."><plain>The frequency of <z:mp ids='MP_0011356'>RAS</z:mp> mutations in de novo <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMLs</z:e> with MLL gene translocations is similar to that in other forms of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, but <z:mp ids='MP_0011356'>RAS</z:mp> mutations play a limited role in lymphoid and treatment-related <z:hpo ids='HP_0001909'>leukemias</z:hpo> with similar translocations </plain></SENT>
</text></document>